Evidence map›Paper›PMID 25925689›Full record

ArticleBMC neuroscience2015

Time dynamics of protein complexes in the AD11 transgenic mouse model for Alzheimer's disease like pathology.

Ivan Arisi, Mara D'Onofrio, Rossella Brandi, Antonino Cattaneo, Paola Bertolazzi, Fabio Cumbo, Giovanni Felici, Concettina Guerra

Open access · goldAbstract read
In one paragraph

Article in BMC neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Ivan ArisiGenomics Facility, European Brain Research Institute (EBRI) Rita Levi-Montalcini, Via del Fosso di Fiorano, 64, 00143, Rome, Italy. i.arisi@ebri.it.
Mara D'OnofrioGenomics Facility, European Brain Research Institute (EBRI) Rita Levi-Montalcini, Via del Fosso di Fiorano, 64, 00143, Rome, Italy. mara.donofrio@ebri.it.
Rossella BrandiGenomics Facility, European Brain Research Institute (EBRI) Rita Levi-Montalcini, Via del Fosso di Fiorano, 64, 00143, Rome, Italy. r.brandi@ebri.it.
Antonino CattaneoNeurotrophic Factors and Neurodegenerative Diseases Unit, EBRI, Rome, Italy. antonino.cattaneo@sns.it.
Paola BertolazziIstituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR), Rome, Italy. paola.bertolazzi@iasi.cnr.it.
Fabio CumboIstituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR), Rome, Italy. fabio.cumbo@hotmail.it.
Giovanni FeliciIstituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR), Rome, Italy. giovanni.felici@iasi.cnr.it.
Concettina GuerraIstituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR), Rome, Italy. guerra@cc.gatech.edu.
European Brain Research Institute · ITIstituto di Analisi dei Sistemi ed Informatica Antonio Ruberti · ITGeorgia Institute of Technology · USScuola Normale Superiore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany approaches exist to integrate protein-protein interaction data with other sources of information, most notably with gene co-expression data, to obtain information on network dynamics. It is of interest to look at groups of interacting gene products that form a protein complex. We were interested in applying new tools to the characterization of pathogenesis and dynamic events of an Alzheimer's-like neurodegenerative model, the AD11 mice, expressing an anti-NGF monoclonal antibody. The goal was to quantify the impact of neurodegeneration on protein complexes, by measuring the correlation between gene expression data by different metrics.

resultsData were extracted from the gene expression profile of AD11 brain, obtained by Agilent microarray, at 1, 3, 6, 15 months of age. For genes coding proteins in complexes, the correlation matrix of pairwise expression was computed. The dynamics between correlation matrices at different time points was evaluated: paired T-test between average correlation levels and a normalized Euclidean distance with z-score. We unveiled a differential wiring of interactions in a set of complexes, whose network structure discriminates between transgenic and control mice. Furthermore, we analyzed the dynamics of gene expression values, by looking at changes in gene-to-gene correlation over time and identified those complexes that exhibit a different timedependent behaviour between transgenic and controls. The most significant changes in correlation dynamics are concentrated in the early stage of disease, with higher correlation in AD11 mice compared to controls. Many complexes go through dynamic changes over time, showing the role of the dysfunctional immunoproteasome, as early neurodegenerative disease event. Furthermore, this analysis shows key events in the neurodegeneration process of the AD11 model, by identifying significant differences in co-expression values of other complexes, such as parvulin complex, with a role in protein misfolding and proteostasis, and of complexes involved in transcriptional mechanisms.

conclusionsWe have proposed a novel approach to analyze the network structure of protein complexes, by two different measures to evaluate the dynamics of gene-gene correlation matrices from gene expression profiles. The methodology was able to investigate the re-organization of interactions within protein complexes in the AD11 model of neurodegeneration.

Indexed as

AgingAlzheimer DiseaseAnimalsBrainDatabases, ProteinDisease Models, AnimalFemaleGene ExpressionGene Expression ProfilingMice, TransgenicMicroarray AnalysisTime Factors

Identifiers

PMID25925689
PMCPMC4436769
OpenAlexW1986544263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.